Author

Revathi Paramasivam Oviya

Observed names: Oviya R. Paramasivam, Oviya Revathi Paramasivam

Institution: Sathyabama Institute of Science and Technology

Observed institutions: Cancer Institute (WIA), Anna University, Chennai, Sathyabama Institute of Science and Technology

ORCID: 0000-0003-1556-5234

Observed ORCID: 0000-0003-1556-5234

OpenAlex ID: A5036760721

Mitochondrial ribosomal small subunit proteins (MRPS) MRPS6 and MRPS23 show dysregulation in breast cancer affecting tumorigenic cellular processes

2021 · Revathi Paramasivam Oviya, Gopisetty Gopal, et al. · Gene · 24

Expression and affinity purification of recombinant mammalian mitochondrial ribosomal small subunit (MRPS) proteins and protein–protein interaction analysis indicate putative role in tumourigenic cellular processes

2021 · Oviya Revathi Paramasivam, Gopal Gopisetty, et al. · The Journal of Biochemistry · 16

Oestrogen receptor-independent actions of oestrogen in cancer

2023 · Prarthana Gopinath, Revathi Paramasivam Oviya, et al. · Molecular Biology Reports · 7

Mitochondrial ribosomal small subunit (MRPS) MRPS23 protein–protein interaction reveals phosphorylation by CDK11-p58 affecting cell proliferation and knockdown of MRPS23 sensitizes breast cancer cells to CDK1 inhibitors

2022 · Revathi Paramasivam Oviya, Krishna Priya Thangaretnam, et al. · Molecular Biology Reports · 7

Comprehensive analysis of genomic alterations, clinical outcomes, putative functions and potential therapeutic value of MMP11 in human breast cancer

2020 · Amritha Sathyanarayanan, Aparna Natarajan, et al. · Gene Reports · 5

Active sulfite oxidase domain of Salmonella enterica pathogenic protein small intestine invasive factor E (SiiE): a potential diagnostic target

2019 · Oviya R. Paramasivam, Swati Trivedi, et al. · Applied Microbiology and Biotechnology · 3

Subcellular Organelle Targeting of Mitochondria Using Nanomedicines: Cancer Therapeutics and Theranostics Potential

2020 · Revathi Paramasivam Oviya, Gopisetty Gopal · Current Nanomedicine · 2

Production and characterization of monoclonal antibodies against recombinant extracellular domain of CD99

2018 · Krishna Priya Thangaretnam, Oviya Revathi Paramasivam, et al. · Human Antibodies · 2

Current Perspectives of Matrix Metalloproteinase 11 (MMP11) as a Diagnostic and Therapeutic Target for Cancer

2023 · Asokan Shobana, Remella Venkata Deeksha, et al. · Current Cancer Therapy Reviews · 1

Works count: 9

Citation count: 67

H-index: 5

I10-index: 2